AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10% and APPLICATION SITE DISCOLOURATION

Overview

APPLICATION SITE DISCOLOURATION is the #19 most commonly reported adverse reaction for AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10%, manufactured by Beiersdorf Inc. There are 2 FDA adverse event reports linking AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10% to APPLICATION SITE DISCOLOURATION. This represents approximately 1.1% of all 183 adverse event reports for this drug.

Patients taking AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10% who experience application site discolouration should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

APPLICATION SITE DISCOLOURATION is a less commonly reported adverse event for AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10%, but still significant enough to appear in the safety profile.

Other Side Effects of AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10%

In addition to application site discolouration, the following adverse reactions have been reported for AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10%:

• CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR — 21 reports
• SUNBURN — 20 reports
• PRODUCT EXPIRATION DATE ISSUE — 15 reports
• ACCIDENTAL EXPOSURE TO PRODUCT — 7 reports
• EYE IRRITATION — 7 reports
• ERYTHEMA — 6 reports
• DRUG INEFFECTIVE — 4 reports
• PAIN — 4 reports
• PRURITUS — 4 reports
• RASH — 4 reports

Other Drugs Associated with APPLICATION SITE DISCOLOURATION

The following drugs have also been linked to application site discolouration in FDA adverse event reports:

Does AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10% cause APPLICATION SITE DISCOLOURATION?

APPLICATION SITE DISCOLOURATION has been reported as an adverse event in 2 FDA reports for AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10%. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is APPLICATION SITE DISCOLOURATION with AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10%?

APPLICATION SITE DISCOLOURATION accounts for approximately 1.1% of all adverse event reports for AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10%, making it a notable side effect.

What should I do if I experience APPLICATION SITE DISCOLOURATION while taking AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10%?

If you experience application site discolouration while taking AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10%, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages